Inhibition of eIF2α Dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy

Denis M. Schewe, Julio A. Aguirre-Ghiso

Research output: Contribution to journal › Article › peer-review

131 Scopus citations

Fingerprint

Dive into the research topics of 'Inhibition of eIF2α Dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences